Free Trial

Cullinan Therapeutics (CGEM) SEC Filings & 10K Form

Cullinan Therapeutics logo
$7.94 +0.27 (+3.52%)
Closing price 04:00 PM Eastern
Extended Trading
$7.94 -0.01 (-0.06%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cullinan Therapeutics SEC Filings

DateFilerForm TypeView
06/04/2025
3:04 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:21 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:24 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
5:56 AM
Cullinan Therapeutics (Filer)
Form DEF 14A
04/25/2025
5:58 AM
Cullinan Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:00 AM
Cullinan Therapeutics (Filer)
Form ARS
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:03 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:07 AM
Cullinan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM
Cullinan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
5:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:22 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
5:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
11/12/2024
1:23 PM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:06 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:18 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
11:48 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
10/16/2024
6:17 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
6:13 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:27 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:20 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Click here to see the Tesla shock that could blindside everyone.
08/08/2024
6:15 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CGEM) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners